COST-EFFECTIVENESS OF PROPHYLACTIC USE OF FILGRASTIM IN ADULTS WITH ACUTE LEUKEMIA LYMPHOBLASTIC COLOMBIA

被引:0
|
作者
Casadiego, E. J.
Rojas, Diaz J. A. [1 ]
Bermudez, C. [2 ]
Prieto-Martinez, V [1 ]
Novoa, Urrego J. R. [3 ]
机构
[1] Univ Nacl Colombia, Bogota, Colombia
[2] Inst Nacl Cancerol, Mexico City, DF, Mexico
[3] Univ Nacl Colombia, Fac Ciencias, Bogota, Colombia
关键词
D O I
10.1016/j.jval.2014.03.501
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN106
引用
收藏
页码:A86 / A86
页数:1
相关论文
共 50 条
  • [11] Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States
    Shah, Bijal D.
    Smith, Nathaniel J.
    Feng, Chaoling
    Jeyakumar, Sushanth
    Castaigne, Jean-Gabriel
    Faghmous, Imi
    Masouleh, Behzad Kharabi
    Malone, Daniel C.
    Bishop, Michael R.
    ADVANCES IN THERAPY, 2022, 39 (08) : 3678 - 3695
  • [12] COST-EFFECTIVENESS ANALYSIS OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN BULGARIA
    Djambazov, S.
    Slavchev, G.
    Encheva-Malinova, M.
    Varbanova, V.
    Velchev, M.
    Raduilov, B.
    Vekov, T.
    VALUE IN HEALTH, 2018, 21 : S38 - S38
  • [13] MODELING THE COST-EFFECTIVENESS OF THE PROPHYLACTIC USE OF SSRIS IN THE TREATMENT OF DEPRESSION
    KIND, P
    SORENSEN, J
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 : 41 - 48
  • [14] Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States
    Bijal D. Shah
    Nathaniel J. Smith
    Chaoling Feng
    Sushanth Jeyakumar
    Jean-Gabriel Castaigne
    Imi Faghmous
    Behzad Kharabi Masouleh
    Daniel C. Malone
    Michael R. Bishop
    Advances in Therapy, 2022, 39 : 3678 - 3695
  • [15] COST-EFFECTIVENESS OF POSACONAZOLE VERSUS FLUCONAZOLE IN THE PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS IN ACUTE LEUKEMIA PATIENTS IN COLOMBIA
    Sung, A.
    Monsanto, H.
    Ruiz, J.
    Beltran, C.
    Rojas, M.
    Cortes, M. F.
    Alvarez, C.
    Garzon, J.
    VALUE IN HEALTH, 2017, 20 (09) : A931 - A931
  • [16] Cost-Effectiveness of Treatment of Childhood Acute Lymphoblastic Leukemia with Pegasparaginase and Erwinia Asparaginase: The Impact of Expensive Chemotherapy
    Tong, Wing H.
    van der Sluis, Inge M.
    Alleman, Cathelijne
    van Litsenburg, Raphaele R. L.
    Kaspers, Gertjan
    Pieters, Rob
    Uyl-de Groot, Carin A.
    BLOOD, 2012, 120 (21)
  • [17] BREXUCABTAGENE AUTOLEUCEL FOR ADULT PATIENTS WITH REFRACTORY/RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA: COST-EFFECTIVENESS IN THE CLINICAL SUBSETS
    Marchetti, Monia
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 198 - 198
  • [18] Cost-effectiveness analysis of prophylactic indomethacin
    Moya, MP
    PEDIATRIC RESEARCH, 1999, 45 (04) : 213A - 213A
  • [19] Cost-Effectiveness Analysis of Prophylactic Indomethacin
    Martin P Moya
    Pediatric Research, 1999, 45 (7) : 213 - 213
  • [20] COST-EFFECTIVENESS OF PROPHYLACTIC INTRAVENOUS IMMUNE GLOBULIN IN CHRONIC LYMPHOCYTIC-LEUKEMIA
    WEEKS, JC
    TIERNEY, MR
    WEINSTEIN, MC
    NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (02): : 81 - 86